[1] ISBT.Table of blood group antigens within systems[E B/OL].https://www.isbtweb.org/fileadmin/user_upload/Table_of_blood_group_antigens_within_systems_v10.0_30-JUN-2021.pdf.
[2] MICHELLE L.ERICKSON. Immunologic Concepts in Transfusion Medicine[M],Elsevier, 2020, 149-165.
[3] ROURK A,SQUIRES J E.Implications of the Kidd blood group system in renal transplantation[J]. Immunohematology,2012,28(3):90-94.
[4] TORMEY C A,STACK G.Immunogenicity of blood group antigens:a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies[J]. Blood,2009,114(19):4279-4282.
[5] STACK G,TORMEY C A.Estimating the immunogenicity of blood group antigens:a modified calculation that corrects for transfusion exposures[J]. Br J Haematol,2016,175(1):154-160.
[6] ARTHUR C M,PATEL S R,SMITH N H,et al.Antigen density dictates immune responsiveness following red blood cell transfusion[J]. J Immunol,2017,198(7):2671-2680.
[7] ZHU Y Y,ZOU L,LIU Y C.T follicular helper cells,T follicular regulatory cells and autoimmunity[J]. Int Immunol,2016,28(4):173-179.
[8] VERDUIN E P,BRAND A,VAN DE WATERING L M G,et al. The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness[J]. Transfusion,2016,56(7):1849-1856.
[9] TATARI-CALDERONE Z,MINNITI C P,KRATOVIL T,et al.rs660 polymorphism in Ro52 (SSA1;TRIM 21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease[J]. Mol Immunol,2009,47(1):64-70.
[10] TATARI-CALDERONE Z,TAMOUZA R,LE BOUDER G P,et al. The association of CD81 polymorphisms with alloimmunization in sickle cell disease[J]. Clin Dev Immunol,2013,2013:937846.
[11] ZERRA P E,PATEL S R,JAJOSKY R P,et al.Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice[J]. Blood,2021,138(8):706-721.
[12] CALABRO S,GALLMAN A,GOWTHAMAN U,et al.Bridging channel dendritic cells induce immunity to transfused red blood cells[J]. J Exp Med,2016,213(6):887-896.
[13] TAMAI Y,OHTO H,YASUDA H,et al.Allo-anti-M:detection peaks around 2 years of age,but may be attenuated by red blood cell transfusion[J]. Transfusion,2021,61(9):2718-2726.
[14] HUDSON K E,LIN E,HENDRICKSON J E,et al.Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope[J]. Blood,2010,115(19):3989-3996.
[15] BAINE I,BAHAR B,HENDRICKSON J E,et al.Microbial pathogen primary sequence inversely correlates with blood group antigen immunogenicity[J]. Transfusion,2019,59(5):1651-1656.
[16] OLSSON M L,SMYTHE J S,HANSSON C,et al.The Fyxphenotype is associated with a missense mutation in theFyballele predicting Arg89Cys in the Duffy glycoprotein[J]. Br J Haematol,1998,103(4):1184-1191.
[17] PARASOL N,REID M,RIOS M,et al.A novel mutation in the coding sequence of the FY*B allele of the Duffy chemokine receptor gene is associated with an altered erythrocyte phenotype[J]. Blood,1998,92(7):2237-2243.
[18] ZIMRING J C,SPITALNIK S L,ROBACK J D,et al.Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens:a novel hypothesis[J]. Transfusion,2007,47(12):2189-2196.
[19] SULLIVAN H C,ARTHUR C M,THOMPSON L,et al.Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion[J]. Transfusion,2018,58(2):542-544.
[20] ZIMRING J C,HAIR G A,CHADWICK T E,et al.Nonhemolytic antibody-induced loss of erythrocyte surface antigen[J]. Blood,2005,106(3):1105-1112.
[21] SULLIVAN H C,GERNER-SMIDT C,NOOKA A K,et al.Daratumumab (anti-CD38) induces loss of CD38 on red blood cells[J]. Blood,2017,129(22):3033-3037.
[22] HARTLEY S B,CROSBIE J,BRINK R,et al.Eliminati on from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens[J]. Nature,1991,353(6346):765-769.
[23] AUFFRAY I,MARFATIA S,DE JONG K,et al.Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis:in vivo studies in human glycophorin A transgenic mice[J]. Blood,2001,97(9):2872-2878.
[24] SMITH N H,HENRY K L,CADWELL C M,et al.Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells[J]. Transfusion,2012,52(12):2620-2630.
[25] KUMPEL B M,ELSON C J.Mechanism of anti-D-mediated immune suppression-a paradox awaiting resolution?[J]. Trends Immunol,2001,22(1):26-31.
[26] BRINC D,LAZARUS A H.Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn[J]. Hematology,2009,2009(1):185-191.
[27] BRINC D,LE-TIEN H,CROW A R,et al.IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion:implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?[J]. Br J Haematol,2007,139(2):275-279.
[28] MAIER C L,MENER A,PATEL S R,et al.Antibody-mediated immune suppression by antigen modulation is antigen-specific[J]. Blood Adv,2018,2(21):2986-3000. |
